Christina Keavaney’s Post

View profile for Christina Keavaney, graphic

Columbia University & The Rockefeller University MilliporeSigma Account Manager

In an insightful segment from the webinar "Impact of Synthia on GSK Chemical Development," we explored the daily challenges that organic chemists face. Synthesizing new target molecules is a complex task, especially when additional constraints such as cost, efficiency, and safety are considered. 👩🔬 Dr. Ewa Gajewska demonstrated how SYNTHIA™ Retrosynthesis Software is transforming the laboratory by translating complex chemical knowledge into a language that computers can process. SYNTHIA™ handles multiple constraints with ease, optimizing processes that once took days into mere minutes. 💡 Imagine devising shorter, more selective synthesis routes that utilize cost-effective materials and avoid hazardous reactions—all at the click of a button. 🚀 Thanks to SYNTHIA™, what once seemed like a bottleneck in the chemical synthesis process is now a gateway to rapid, innovative solutions. This tool is not only speeding up drug development and pathway discovery as highlighted by John Jin Lim from GSK but is also setting new benchmarks in synthetic chemistry. 🔗 Watch the full webinar to witness how SYNTHIA™ is revolutionizing retrosynthesis, making it an essential ally for every chemist striving for excellence in their field. https://lnkd.in/ePzSthmy #Chemistry #Innovation #OrganicChemistry #Synthesis #SYNTHIA #DigitalTransformation #TeamMilliporeSigma

To view or add a comment, sign in

Explore topics